pin
| Program | Indication | Target | Preclinical | Phase 1 | Phase 2 | Phase 3 | Partner |
|---|---|---|---|---|---|---|---|
| EB613 | Osteoporosis | PTH 1-34 | Undisclosed MTA + Collaboration | ||||
| EB612 | Hypoparathyroidism | PTH 1-34 | |||||
| OXM | Obesity / Metabolic | GLP-1 & Glucagon Agonist |  |
||||
| GLP-2 | Short Bowel Syndrome | Long Acting GLP-2 | |
||||
| EB613 | Stress Fractures | PTH 1-34 | Investigator Sponsored Trial | ||||
